Kezar Life Sciences, Inc. (KZR) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts KZR Hot Sheet
Join SI Premium – FREE
Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and memory not a classic bubble, but future returns uncertain - strategist
- Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
- Darden Restaurants falls as Q1 revenue misses expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
